ArticleInfection and drug resistance2026
Temporal Trends in Antimicrobial Resistance in a Tertiary Hospital in Western Guangxi, China: A Five-Year Surveillance Study (2021-2025).
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although antimicrobial resistance (AMR) exhibits substantial regional heterogeneity, data from western Guangxi in Southwest China remain limited. To address this gap, we conducted a five-year surveillance study at a tertiary hospital in this area to characterize pathogen distribution, resistance trends, and discrepancies compared with national benchmarks. Methods: All non-duplicate clinical bacterial isolates collected between January 2021, and December 2025 were included. Species identification and antimicrobial susceptibility testing were performed using MALDI-TOF MS and the VITEK 2 system. Results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) criteria. Resistance trends were analyzed using WHONET software, and chi-square tests and trend analyses were applied to evaluate temporal changes and to compare findings with data from the China National Surveillance System (CHINET). Results: Among 57,157 clinical isolates, Gram-negative bacteria predominated (71.0%), with Conclusion: This study describes antimicrobial resistance patterns in a tertiary hospital in western Guangxi, China, with an increasing trend in CRPAE, while CRECO remained below 5% but was relatively higher than that reported in CHINET data, warranting continued surveillance. These findings underscore the essential role of regional surveillance and highlight the need for continued monitoring and strengthened antimicrobial stewardship, particularly in ICU settings and pediatric respiratory infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.